Adma Biologics ADMA Income Statement (2011-2026)

NASDAQ ADMA
$9.51 -0.07 (-0.74%)
As of: Sep 4, 2026 · 11:47 AM EDT
Reported Financials

Adma Biologics Quarterly Income Statement

Periods 53 quarters
Latest Jun 2026

Adma Biologics reported revenue of $124.39M and net income of $37.82M for the quarter ended Jun 2026, up 2.0% year over year. This income statement covers 53 quarters of results from Mar 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Dec2014 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
20.68M55.00M29.10M33.91M41.09M49.98M56.91M60.12M67.28M73.90M81.88M107.19M119.84M117.55M114.80M121.98M134.22M139.16M114.49M124.39M
Cost of RevenueCost of Rev
20.30M22.87M25.44M26.14M31.43M35.80M40.40M0.70M42.62M42.82M42.77M49.74M60.18M54.22M53.70M54.76M58.60M50.35M33.74M38.12M
Gross Profit
0.39M3.51M3.66M7.77M9.66M14.18M16.51M16.69M24.65M31.09M39.11M57.45M59.66M63.33M61.10M67.23M75.63M88.82M80.75M86.28M
Operating items
Amortization - Intangibles
0.20M0.18M0.20M0.20M0.20M0.18M0.20M0.20M0.20M0.19M0.19M0.14M0.03M0.03M0.03M0.03M0.04M0.05M0.06M0.06M
Research & DevelopmentR&D
0.77M0.73M0.62M0.87M1.04M1.07M0.85M1.40M0.60M0.45M0.45M0.56M0.41M0.39M0.83M1.03M1.53M1.38M2.60M6.01M
Selling, General & AdministrativeSG&A
10.73M11.70M13.70M11.97M12.89M13.89M14.51M14.25M14.73M15.54M15.64M16.61M18.56M23.32M24.08M22.21M21.78M23.51M26.74M26.74M
Other Operating ExpensesOther Opex
3.33M4.28M4.15M4.10M5.04M5.27M1.96M1.51M0.65M0.87M1.20M1.08M1.05M1.30M1.31M1.18M1.31M1.18M-6.86M1.08M
Operating ExpensesOpex
14.82M16.70M18.48M16.94M18.97M20.24M17.33M17.16M15.97M16.85M17.29M18.25M20.02M25.01M26.22M24.43M24.61M26.07M22.48M33.83M
Operating IncomeOp. Inc
-14.44M-13.19M-14.82M-9.17M-9.32M-6.06M-0.81M-0.47M8.69M14.23M21.82M39.20M39.64M38.32M34.88M42.80M51.01M62.75M58.27M52.45M
EBIT
-14.44M-13.19M-14.82M-9.17M-9.32M-6.06M-0.81M-0.47M8.69M14.23M21.82M39.20M39.64M38.32M34.88M42.80M51.01M62.75M58.27M52.45M
Non-operating items
Non Operating Interest Expenses
3.30M3.32M3.39M4.57M5.58M5.74M6.12M6.30M6.40M6.21M3.77M3.78M3.50M2.88M1.98M1.83M1.68M1.63M2.10M3.42M
Non Operating Investment IncomeNon-Op. Investment Inc.
7.98M
Interest & Investment IncomeInt & Inv Inc
0.00M0.00M0.03M0.00M0.01M0.00M0.17M0.41M0.42M0.61M0.38M0.45M0.67M0.60M0.61M0.40M0.38M0.49M1.09M1.24M
Other Non Operating IncomeOther Non Op Inc.
0.02M-0.15M-6.67M-0.02M-0.01M-59.00-0.03M-0.01M-0.14M-25.99M-0.04M-0.02M-0.06M-1.14M-0.06M-1.16M-2.18M-0.14M-0.02M
Non Operating IncomeNon Op. Inc.
-3.28M-3.46M-10.19M-4.59M-5.58M-6.17M-5.98M-5.90M-6.12M-31.88M-3.42M-3.35M-2.89M-3.61M-1.43M-2.70M-3.50M-1.16M-1.15M-2.21M
Net income details
EBT
-17.73M-16.50M-18.17M-13.75M-14.89M-11.79M-6.79M-6.37M2.56M-17.64M18.40M35.85M36.75M34.71M33.45M40.10M47.52M61.59M57.13M50.24M
Tax ProvisionsTaxes
-5.93M0.59M3.79M0.84M-77.18M6.55M5.88M11.09M14.85M11.80M12.41M
Profit After TaxPAT
-17.71M-16.65M-25.01M-13.76M-14.90M-12.23M-6.79M-6.37M2.56M-17.64M17.81M32.06M35.91M111.90M26.90M34.22M36.43M49.38M45.33M37.82M
Income from Continuing OperationsIncome (Continuing)
-17.73M-16.50M-18.17M-13.75M-14.89M-11.79M-6.79M-6.37M2.56M-11.71M17.81M32.06M35.91M111.90M26.90M34.22M36.43M46.75M45.33M37.82M
Consolidated Net IncomeConsol Net Inc.
-17.73M-16.50M-18.17M-13.75M-14.89M-11.79M-6.79M-6.37M2.56M-11.71M17.81M32.06M35.91M111.90M26.90M34.22M36.43M46.75M45.33M37.82M
Income towards Parent CompanyParent Net Inc
-17.73M-16.50M-18.17M-13.75M-14.89M-11.79M-6.79M-6.37M2.56M-11.71M17.81M32.06M35.91M111.90M26.90M34.22M36.43M46.75M45.33M37.82M
Net Income towards Common StockholdersNet Income
-17.73M-16.50M-18.17M-13.75M-14.89M-11.79M-6.79M-6.37M2.56M-11.71M17.81M32.06M35.91M111.90M26.90M34.22M36.43M46.75M45.33M37.82M
Additional items
EPS (Basic)
-0.13-0.12-0.09-0.07-0.08-0.06-0.03-0.030.01-0.050.080.140.150.480.110.140.150.200.190.17
EPS (Diluted)
-0.13-0.12-0.09-0.07-0.08-0.06-0.03-0.030.01-0.050.080.130.150.460.110.140.150.190.190.16
Shares Outstanding
133.77M139.58M195.87M196.35M196.38M197.87M221.92M222.68M225.28M223.98M228.87M232.42M234.57M233.08M237.78M241.49M238.60M238.30M236.07M228.23M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
133.77M139.58M195.87M196.35M196.38M197.87M221.92M222.68M233.76M223.98M236.41M242.17M244.80M243.34M244.68M248.61M244.66M244.90M239.96M230.34M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
138.31M139.58M196.35M196.36M196.78M221.82M222.26M224.53M225.96M226.06M231.77M233.03M236.38M236.62M238.53M238.57M238.33M237.87M232.29M225.36M
EBITDA
-14.44M-13.19M-14.82M-9.17M-9.32M-6.06M-0.81M-0.47M8.69M14.23M21.82M39.20M39.64M38.32M34.88M42.80M51.01M62.75M58.27M52.45M
Interest ExpensesInt Expense
3.30M3.32M3.39M4.57M5.58M5.74M6.12M6.30M6.40M6.21M3.77M3.78M3.50M2.88M1.98M1.83M1.68M1.63M2.10M3.42M
Tax Rate
33.61%3.23%10.57%2.29%-222.35%19.57%14.66%23.33%24.11%20.65%24.71%